Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Liquidia is a US-based biopharmaceutical company specializing in the development of innovative therapies using advanced PRINT technology. The company focuses on optimizing medicines for the treatment of rare diseases, with a particular emphasis on pulmonary hypertension.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Liquidia is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Liquidia last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at 0.74 USD.
Across its last 3 earnings reports, Liquidia stock moved by ±12.2% on average the following day. The largest reaction was +25.6% on 05/11/2026; 2 of 3 reactions were positive.
Liquidia has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.